CIK 0001062822
- Non-accelerated filer
- Smaller reporting company
LEXICON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- LXRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760474169
- Phone
- +1 281-863-3000
- Business address
- 2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
- Former names
- LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
- Open-market buys, last 90 days
- $49,999
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$49,999. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-10 | MAIN ALAN J EVP, Innov & Chem Sciences | Grant or award · Stock Option (Right to Buy) | +230,990 | 230,990 | ||
| 2022-02-10 | MAIN ALAN J EVP, Innov & Chem Sciences | Grant or award · Restricted Stock Units | +77,000 | 77,000 | ||
| 2022-02-10 | Seth Kiernan VP, Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +206,670 | 206,670 | ||
| 2022-02-10 | Seth Kiernan VP, Chief Commercial Officer | Grant or award · Restricted Stock Units | +68,890 | 68,890 | ||
| 2022-02-10 | WADE JEFFREY L President and CFO | Grant or award · Stock Option (Right to Buy) | +335,470 | 335,470 | ||
| 2022-02-10 | WADE JEFFREY L President and CFO | Grant or award · Restricted Stock Units | +111,820 | 111,820 | ||
| 2022-02-10 | Kassler-Taub Kenneth B. SVP, Regulatory & QA | Grant or award · Stock Option (Right to Buy) | +248,010 | 248,010 | ||
| 2022-02-10 | Kassler-Taub Kenneth B. SVP, Regulatory & QA | Grant or award · Restricted Stock Units | +82,670 | 82,670 | ||
| 2022-02-10 | COATS LONNEL Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +822,280 | 822,280 | ||
| 2022-02-10 | COATS LONNEL Chief Executive Officer | Grant or award · Restricted Stock Units | +274,090 | 274,090 | ||
| 2022-02-10 | Granowitz Craig B SVP, Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +251,250 | 251,250 | ||
| 2022-02-10 | Granowitz Craig B SVP, Chief Medical Officer | Grant or award · Restricted Stock Units | +83,750 | 83,750 | ||
| 2022-02-10 | Crum Brian T SVP, General Counsel & Secr. | Grant or award · Stock Option (Right to Buy) | +234,870 | 234,870 | ||
| 2022-02-10 | Crum Brian T SVP, General Counsel & Secr. | Grant or award · Restricted Stock Units | +78,290 | 78,290 | ||
| 2022-02-10 | Alexander Kristen VP, Finance and Accounting | Grant or award · Stock Option (Right to Buy) | +47,780 | 47,780 | ||
| 2022-02-10 | Alexander Kristen VP, Finance and Accounting | Grant or award · Restricted Stock Units | +31,850 | 31,850 | ||
| 2022-01-03 | McDermott Wendy VP, Human Resources | Grant or award · Stock Option (Right to Buy) | +85,185 | 85,185 | ||
| 2021-08-02 | Granowitz Craig B SVP, Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2021-04-30 | SOBECKI CHRISTOPHER J Director | Grant or award · Restricted Stock Units | +4,024 | 4,024 | ||
| 2021-04-30 | SOBECKI CHRISTOPHER J Director | Grant or award · Stock Option (Right to Buy) | +6,475 | 6,475 |
Page 26 of 27 · 540 trades